Introduction {#sec1}
============

*Neisseria meningitidis* is an etiological factor of invasive meningococcal disease (IMD), which is an acute, infectious illness characterized by a severe clinical course, even if antibiotics are administered at an early stage and intensive care is provided ([@bib28]). This Gram-negative diplococcus colonizes the nasopharyngeal mucosa and is transmitted from person to person via droplets or through a direct physical contact with secretions of infected patients or asymptomatic carriers, who account for 5--10% of the general population ([@bib31]). It is estimated, that carriage rates of *N. meningitidis* in closed environments (dormitories, military units) may be significantly higher and reach \> 40% ([@bib37]). Until now, twelve meningococcal serogroups have been described (they are distinguished according to biochemical constitution of the polysaccharide capsules of bacteria). The groups of *N. meningitidis* mostly associated with IMD are A, B, C, W and Y ([@bib29]). Serogroup incidence varies depending on the geographical area ([@bib18]). Groups B and C are a main cause of IMD in Americas and Europe. It is estimated that there are 1.2 million new IMD cases worldwide every year, with mortality reaching 10% or even 70% in cases of a septic shock ([@bib28]). In Poland, IMD incidence was found to be 0.43/100 000 in 2016 and 0.58/100 000 in 2017 ([@bib26]). IMD cases have also been reported among the Polish military personnel: four cases in the military base in Skwierzyna, including two deaths in 2006 ([@bib16]), 15 cases in a military base in Warsaw, including two deaths in 2007 ([@bib20]), and one death from IMD in the Polish Military Contingent in Afghanistan ([@bib21]). The incidence of IMD in US military personnel, historically far above that in the general population, has decreased \> 90% since in early 1970s, when the first vaccine against meningococcal infections was introduced ([@bib5]). Over the last decade, incidences of IMD in the military and US general population have become equivalent ([@bib4]).

Meningococcal carriage studies conducted among European conscripts over the last several decades demonstrated high carriage incidence, often exceeding 30%. The studies by [@bib36] carried out in the last decade of the 20^th^ century revealed that *N. meningitidis* carriage incidence among Polish conscripts was 60%. However, in 2009 Poland suspended conscription and transformed its national army into a fully professional organization. Recruits have been replaced by professional soldiers, whose socio-demographic profile as well as the character of work/service they perform is different from that of young conscripts who used to serve on a 24/7 basis and were permanently assigned to a given military facility. The first study presenting the general prevalence of *N. meningitidis* carriage in professional soldiers in Poland was conducted in winter season of 2016. The overall carrier rate among 1246 soldiers from the Armoured Brigade amounted to 5.2% (single examination), with the serogroup B being predominant ([@bib22]).

The aim of the present study was to estimate the actual *N. meningitidis* carriage rate in the military environment with identification of serogroups, genogroups, sequence types and clonal complexes of the isolates (including clonal complexes responsible for IMD) detected among Polish soldiers.

Experimental {#sec2}
============

Materials and Methods {#sec3}
---------------------

**Study population.** A total of 1766 biological samples from nasopharyngeal mucosa were taken from 883 professional soldiers serving in the 10^th^ Armoured Brigade in Świętoszów, Poland (the first sample was collected in 2015, the second in 2016 from the same individual). The soldiers were joining the study group during the winter season (January--March); all of the participants had to provide informed consent and complete a socio-demographic and behavioral questionnaire including information on their military rank, age, sex, place of residence, cigarette smoking, medications taken on a regular basis, and vaccinations received against meningococcal serogroups A, C, W-135, Y (18% of examined soldiers were vaccinated between 2008 and 2014). Only professional soldiers, men or women aged 21--59 years (median 31 years), with 1--26 years of military service, in a good health condition were involved in the study. Soldiers with any anatomical or pathological lesions in the nasopharynx, which could prevent the collection of samples were excluded from the study.

**Ethical Procedure.** A research task was approved by the Ethics Committee of the Military Institute of Medicine in Warsaw, Poland (Decision No. 24/WIM/2014 of 18 Aug 2014).

**Identification of isolates.** The specimens obtained from the nasopharynx were transported to the microbiological laboratory in the Military Institute of Medicine, Warsaw, where they were plated onto the appropriate medium, i.e. Columbia Agar with 5% sheep blood and PoliVitex VCA3 and incubated under elevated CO~2~ concentration at 37°C for 48 hours. After incubation, the colonies grown were macroscopically evaluated. Colonies morphologically similar to *N. meningitidis* phenotypes were isolated onto Columbia Agar with 5% sheep blood and were incubated under elevated CO~2~ concentration at 37°C for 24 hours. The incubated pure colonies of bacteria were used to prepare Gram-stained preparations, which were then observed under a light microscope. Catalase and cytochrome oxidase tests were performed. All Gram-negative strains were identified based on their biochemical features using Vitek 2 NH card. The strains identified as *N. meningitidis* were stored frozen in a temperature of --20°C and then transported to the National Reference Center for the Diagnostics of Bacterial Infections of the Central Nervous System (KOROUN) in Warsaw, Poland for further diagnostics.

**Serogrouping.** The strains delivered to KOROUN were revived by placing them onto Columbia Agar medium; they were incubated in elevated CO~2~ atmosphere at 37°C for 24 hours. Serogroups of all isolates were identified with a slide agglutination test using a set of primers in compliance with the manufacturer's instructions (detection of capsular antigens of *N. meningitidis*). The specific reagents covered the following serogroups: A, B, C, Y and W (Remel), E29 (Bio-Rad), X and Z (Becton Dickinson). Typing was performed on colonies isolated from the Mueller-Hinton agar medium following the identification of the strains.

**Genogrouping.** Chromosomal DNA was isolated from meningococcal isolates with Genomic DNA Prep Plus (A&A Biotechnology) following the manufacturer's recommendations. Genogroups were identified with the PCR assay using genogroup-specific oligonucleotide primers *orf-2*(A), *siaD*(C), *siaD*(W135) and *siaD*(Y) described by [@bib33] and *siaD*(B) described by [@bib17]. The products were analyzed on the agarose gel. Genogroups A, B, C, E29, W, Y were identified.

**Sequencing.** Sequencing was performed on seven DNA fragments of the isolated strains. The chromatograms were analyzed using the Seqed 10.3 programme (Applied Biosystems) and the sequences obtained from the specimens were compared with the sequences available in the international database (<http://pubmlst.org/neisseria/>). Individual loci were assigned to the right alleles. We identified the sequence type (ST) and clonal complex (CC) of the isolates which had a complete allelic profile (seven loci). In the case of isolates whose allelic profile was incomplete, only the clonal complex was identified.

**Statistics.** Statistical analysis was performed using STATISTICA PL version 12.0 and Microsoft Excel 2013. The quantitative variables were counted by arithmetic mean ± SD or median and 95% confidence interval. The qualitative variables were introduced in the absolute or percentage terms. Significance of differences between two groups was processed with the t-Student or U Mann-Whitney test. In all the calculations *p*-value under 0.05 was considered statistically significant.

Results {#sec4}
=======

A nasopharyngeal culture sample was collected twice during winter seasons (in 2015 and then in 2016) from 883 soldiers. 76 of the subjects tested were found to be carriers (at least one of the single samples collected in 2015 and 2016 was positive for *N. meningitidis*); the carriers accounted for 8.6% of the study group. In 2015, genogroups were determined for 46 isolates: B (n = 33, 61.1%), E29 (n = 6, 11.1%), C (n = 4, 7.4%), Y (n = 2, 3.7%), W (n = 1, 1.9%). Eight isolates were non-groupable (NG, 14.8%) with the primers used. In 2016, genogroups were determined for 46 isolates: B (n = 24, 45.3%), E29 (n = 8, 15.1%), C (n = 6, 11.3%), Y (n = 6, 11.3%), W (n = 2, 3.8%); genogroups of 7 isolates (NG, 13.2%) could not be determined with the primers used (Fig. [1](#fig1){ref-type="fig"}).

![Percentage distribution of *N. meningitidis* genogroups among Polish soldiers tested in years 2015--2016.](pjm-67-4-493-g001){#fig1}

Based on the MLST analysis, 21 different sequence types were identified among the isolates analyzed. Although the analysis was repeated several times, the sequence type and clonal complex of one of the isolates of genogroup B could not be determined in 2016. In both studies, 12 clonal complexes (CC) were identified among 62 *N. meningitidis* strains (25 isolates were identical to each other in both years, 12 were isolated once only). The most common clonal complexes included: 41/44CC (n = 6), 1136CC (n = 2), 53CC (n = 2). Only five strains which were found in both studies (in 2015 and again in 2016) and two strains isolated in 2016 were not assigned to any clonal complex. In six carriers the authors observed a change in the sequence type at the second collection and in four carriers also a change in the clonal complex. In one carrier genogroup B was found at the first collection and was replaced by genogroup Y at the second collection (Table [I](#tblI){ref-type="table"}).

###### 

Distribution of sequence types (ST), clonal complexes and genogroups of the *N. meningitidis* isolates tested in years 2015--2016.

![](pjm-67-4-493-t001)

  ST 2015                                              Clonal complex 2015          ST 2016                                   Clonal complex 2016
  ---------------------------------------------------- ---------------------------- ----------------------------------------- -----------------------------------------
  Genogrup B                                                                                                                  
  136                                                  ST-41/44 complex/Lineage 3   136                                       ST-41/44 complex/Lineage 3
  136                                                  136                                                                    
  136                                                  136                                                                    
  1097                                                 1097                                                                   
  2840                                                 2840                                                                   
  11442                                                8107                         ST-213 complex                            
  1732                                                 negative                     negative                                  
  112                                                  negative                     negative                                  
  973                                                  negative                     negative                                  
  35                                                   ST-35 complex                35                                        ST-35 complex
  35                                                   negative                     negative                                  
  35                                                   negative                     negative                                  
  35                                                   negative                     negative                                  
  162                                                  ST-162 complex               162                                       ST-162 complex
  162                                                  4509                         --                                        
  162                                                  negative                     negative                                  
  162                                                  negative                     negative                                  
  11433                                                ST-213 complex               11433                                     ST-213 complex
  213                                                  negative                     negative                                  
  33                                                   ST-32 complex                negative                                  negative
  33                                                   negative                     negative                                  
  32                                                   negative                     negative                                  
  11440                                                ST-1136 complex              11440                                     ST-1136 complex
  2126                                                 ST-53 complex                2126                                      ST-53 complex
  198                                                  ST-198 complex               198                                       ST-198 complex
  1001                                                 ST-18 complex                11446                                     --
  11436                                                ST-364 complex               negative                                  negative
  5133                                                 ST-103 complex               negative                                  negative
  9316                                                 9316                         --                                        
  1572                                                 1572                         --                                        
  11444                                                negative                     negative                                  
  11447                                                negative                     negative                                  
  negative                                             negative                     35                                        ST-35 complex
  negative                                             negative                     11436                                     ST-364 complex
  negative                                             negative                     36                                        --
  negative                                             negative                     12187                                     --
  negative                                             negative                     9157                                      --
  negative                                             negative                     12186                                     --
  negative                                             negative                     120                                       --
  negative                                             negative                     undetermined^[1](#FNt1){ref-type="fn"}^   undetermined^[1](#FNt1){ref-type="fn"}^
  Genogrup E29                                                                                                                
  11434                                                ST-254 complex               11434                                     ST-254 complex
  11438                                                11438                        --                                        
  1138                                                 ST-60 complex                1138                                      ST-60 complex
  11439                                                11439                        --                                        
  11439                                                11439                        --                                        
  11445                                                ST-60 complex                negative                                  negative
  negative                                             negative                     1157                                      ST-1157 complex
  negative                                             negative                     60                                        ST-60 complex
  negative                                             negative                     11438                                     ST-11438 complex
  Genogrup C                                                                                                                  
  2433                                                 ST-41/44 complex/Lineage 3   2433                                      ST-41/44 complex/Lineage 3
  2003                                                 --                           2003                                      --
  5238                                                 --                           negative                                  negative
  5133                                                 ST-103 complex               negative                                  negative
  negative                                             negative                     3346                                      ST-41/44 complex/Lineage 3
  negative                                             negative                     3346                                      
  negative                                             negative                     2433                                      
  negative                                             negative                     8108                                      ST-174 complex
  Genogrup Y                                                                                                                  
  767                                                  ST-167 complex               767                                       ST-167 complex
  9316                                                 --                           9316                                      --
  negative                                             negative                     767                                       ST-167 complex
  negative                                             negative                     767                                       
  negative                                             negative                     3342                                      ST-865 compex
  Genogrup W                                                                                                                  
  112                                                  ST-41/44 complex/Lineage 3   112                                       ST-41/44 complex/Lineage 3
  negative                                             negative                     22                                        ST-22 complex
  NG                                                                                                                          
  9268                                                 ST-53 complex                9268                                      ST-53 complex
  10159                                                                             53                                        
  53                                                                                negative                                  negative
  1136                                                 ST-1136 complex              1136                                      ST-1136 complex
  1136                                                                              negative                                  negative
  198                                                  ST-198 complex               negative                                  negative
  198                                                                               negative                                  negative
  11441                                                ST-364 complex               11441                                     ST-364 complex
  negative                                             negative                     4431                                      ST-41/44 complex/Lineage 3
  negative                                             negative                     3461                                      
  negative                                             negative                     9466                                      
  Genogrup B / Genogrup Y^[2](#FNt2){ref-type="fn"}^                                                                          
  11437                                                ST-41/44 complex/Lineage 3   92                                        ST-92 complex

Sequence type and clonal complex could not be determined

Genogroup B was identified in the first collection and genogroup Y was detected in the second collection

The mean age of *N. meningitidis* carriers in the study group was 30.4 ± 4.7 years and of non-carriers it was 32.1 ± 5.3 years. Carriers were significantly younger (*p* = 0.0083). No statistically significant differences were found between carriage prevalence and sex or residence. There were significantly more tobacco smokers among *N. meningitidis* carriers than in the non-carrier group (51.3% vs. 32.8%; *p* = 0.0012). The distribution of military ranks in both groups (carriers vs. non-carriers) was found to be statistically significant (*p* = 0.0088), the corps of privates being the largest. There were no statistically significant differences between carrier state and prior vaccination against *N. meningitidis* (Table [II](#tblII){ref-type="table"}).

###### 

Socio-demografic variables between control group (non-carriers) and carriers of *N. meningitidis* in years 2015--2016.

![](pjm-67-4-493-t002)

  Socio-demographic variables       Control group (non-carriers n = 807)   Carriers (n = 76)   p-value
  --------------------------------- -------------------------------------- ------------------- ---------
  **Age**                                                                  0.0083              
  Mean (SD)                         32.1 (5.3)                             30.4 (4.7)          
  Range                             21.0--59.0                             23.0--45.0          
  Median                            31.0                                   30.0                
  **Sex**                                                                  0.6490              
  Women                             65 (8.1%)                              5 (6.6%)            
  Men                               742 (91.9%)                            71 (93.4%)          
  **Place of residence**                                                   0.3318              
  Rural area                        322 (39.9%)                            26 (34.2%)          
  Urban area                        485 (60.1%)                            50 (65.8%)          
  **Smoking cigarettes**                                                   0.0012              
  Yes                               265 (32.8%)                            39 (51.3%)          
  No                                542 (67.2%)                            37 (48.7%)          
  **Respiratory tract infection**                                          0.1106              
  Yes                               61 (7.6%)                              2 (2.6%)            
  No                                746 (92.4%)                            74 (97.4%)          
  **Military rank**                                                        0.0088              
  Private                           479 (59.4%)                            57 (75.0%)          
  Non-commissioned officer          276 (34.2%)                            19 (25.0%)          
  Officer                           52 (6.4%)                              0 (0.0%)            
  **Vaccination**                                                          0.1567              
  Yes                               148 (18.3%)                            9 (11.8%)           
  No                                659 (81.7%)                            67 (88.2%)          

Discussion {#sec5}
==========

*N. meningitidis*, the etiological factor of invasive meningococcal disease (IMD), can be the cause of meningitis and/or sepsis. In most cases, meningococcal carriage does not lead to invasive disease, but is limited to asymptomatic carrier state which is normally found in 5--10% of the general population ([@bib38]). In Poland, there have been reports of IMD cases in recent years; however, the actual carriage incidence of *N. meningitidis* among Polish residents has not been determined ([@bib18]). Many of Polish and European publications on the *N. meningitidis* carriage incidence are limited to military environment ([@bib10]; [@bib37]; [@bib23]). According to the research findings, meningococcal carriage is high among conscripted soldiers serving in European armies, whereas among professional soldiers it was found to be like the carriage rates observed in the general population ([@bib22]). Meningococcal carriage studies conducted among military personnel also revealed that serogroup B was the most prevalent ([@bib33]). In Denmark, 43% of newly drafted recruits were found to be carriers of *N. meningitidis*, of whom 34% were transient carriers (this was associated with the colonization variability in the nasopharyngeal mucosa); 34% of the strains isolated from carriers belonged to serogroup B ([@bib1]). The study, which was conducted in six military camps in Bavaria, found that 32% of the soldiers tested were carriers of *N. meningitidis*, and serogroup B was identified in 42% of them ([@bib11]). Exceptionally high rates of meningococcal carriage, over 70%, were observed among British and Norwegian recruits, in whom serogroup B was also the most commonly found ([@bib15]; [@bib6]). There have been very few meningococcal carriage surveillance studies outside Europe. One of such studies, with the participation of Iranian soldiers, demonstrated that the incidence of *N. meningitidis* carriage among newly drafted soldiers was 11%, but after 2 months of service it increased to 33%. The study also revealed that serogroup B was predominant among the recruits tested ([@bib14]). A study involving Iranian recruits which was performed a decade later demonstrated a lower carriage rate (8%), with a dominance of serogroup C ([@bib2]). A research study into Polish recruits carried out between 1998 and 1999 demonstrated meningococcal carriage rate at 31%, with the predominance of serogroup B ([@bib36]; [@bib37]). The first meningococcal carriage study in Polish professional soldiers (n = 559), which was conducted in 2013, showed the incidence of *N. meningitidis* carriage at 5.7% ([@bib23]). A significant factor contributing to a reduction in meningococcal carriage incidence in the military environment was a change in the character of military service after the Polish Armed Forces have been transformed into a professional organization. Recruits used to serve on a 24/7 basis, they were permanently accommodated in the barracks and had all their meals in military dining facilities. Professional soldiers, on the other hand, typically work 8 hours a day and they are accommodated outside the military facilities (professional military service has changed to a regular job, with risk factors similar to those observed in the civilian environment). Another factor contributing to decreasing of meningococcal carriage prevalence was raise of the age of soldiers (19--20 year old recruits vs. professional privates who usually begin their military career at the age of 25--30 years old) ([@bib22]). Meningococcal vaccination may also have a positive impact on reducing carriage prevalence of *N. meningitidis* and lowering the number of new IMD cases; however, its effectiveness varies depending on the type of vaccine used, with conjugate vaccines being the most effective ([@bib12]). It needs to be pointed out that meningococcal vaccination does not completely prevent individuals from acquiring an infection, e.g. cases of the disease were reported among French soldiers, despite the use of immunoprophylaxis ([@bib13]). The studies with the participation of Polish military personnel demonstrated that meningococcal carriage incidence was lower in older soldiers; the results are consistent with the available research findings ([@bib33]; [@bib38]; [@bib8]; Soriano-Gabarro et al. [@bib31]). Another factor associated with an increased risk for meningococcal carriage was found to be tobacco smoking ([@bib3]; [@bib6]; [@bib22]). The studies by Caugant et al. ([@bib7]) demonstrated that hypervirulent *N. meningitidis* strains rarely colonize the nasopharyngeal mucosa of carriers. The present study, and especially the application of sequencing methods, has proved to be useful in determining the genetic relationship among different strains and estimating the risk for IMD among carriers. The study involving Polish soldiers found virulent strains in 15.8% of carriers (n = 76) and 1.4% of the whole study group (n = 883). Stephens ([@bib32]) estimated that the risk of developing IMD by people living in closed environments is 1--1.5%. The incidence of specific clonal complexes is associated with the dominance of individual serogroups ([@bib34]; [@bib19]). In Poland serogroup B, comprising ST-32CC, ST-18CC, ST-41/44CC, ST-213CC and ST-269, was found to be predominant. Serogroup C covers ST-103CC, ST-41/44CC and ST-11CC. Serogroup W is represented by ST-22CC, and Y by ST-22CC, ST-23CC, ST-92CC, ST-167CC (Skoczyńska et al. [@bib30]; Waśko et al. [@bib39]). The present study confirmed that serogroup B was predominant among carriers; it was mostly represented by ST-41/44CC. Similar sequencing results were observed in Greece in a population of military recruits ([@bib35]). Hypervirulent clonal complexes ST-213CC, ST-213CC, which have been observed in Poland, were also found in the study participants. Among serogroup C isolates the most common were clonal complexes ST-41/44CC and ST-103CC. Serogroup C was the third most common, after serogroup B and E29. Serogroup E29 was represented by the clonal complex ST-254CC and ST-60CC. At present, there is no data available concerning IMD morbidity from this particular serogroup (PubMLST, [@bib27]). Serogroup Y covered the virulent clonal complex ST-167CC and once -- ST-92CC. In this study, among carriers of serogroup W the clonal complex ST-22CC was identified, which was listed by the National Reference Center for the Diagnostics of Bacterial Infections of Central Nervous System in Warsaw as the strain responsible for causing IMD cases in Poland (Skoczyńska et al. [@bib30]). In this current study, the hyperepidemic and hypervirulent strain ST-11 has not been identified. This strain is rarely found in carriers, its carriage is usually transient as the strain is rapidly transmitted to other hosts ([@bib25]). In general, there are significant differences in the incidence of the clonal complexes causing IMD and those responsible for meningococcal carriage ([@bib9]). Studies aimed at detecting pathogenic strains have been found to be valuable in determination of transmission routes, the distribution of individual genogroups and the epidemiological variability of *N. meningitidis*. While the surveillance of circulating strains is useful in selecting the best immunoprophylaxis ([@bib1]).

Conclusions {#sec6}
===========

The overall carriage rates and types of serogroups of *N. meningitidis* among Polish professional soldiers were similar to the carriage reported in the general population. Clonal complexes responsible for IMD were detected in 15.8% of carriers and 1.4% of the whole study participants. Meningococcal carriage in professional soldiers was largely associated with a younger age, low military rank and frequent tobacco smoking.
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